Effect of APOE ε4 allele on survival and fertility in an adverse environment
- PMID: 28683096
- PMCID: PMC5500260
- DOI: 10.1371/journal.pone.0179497
Effect of APOE ε4 allele on survival and fertility in an adverse environment
Abstract
Background: The apolipoprotein-ε4 allele (APOE-ε4) is strongly associated with detrimental outcomes in affluent populations including atherosclerotic disease, Alzheimer's disease, and reduced lifespan. Despite these detrimental outcomes, population frequencies of APOE-ε4 are high. We hypothesize that the high frequency of APOE-ε4 was maintained because of beneficial effects during evolution when infectious pathogens were more prevalent and a major cause of mortality. We examined a rural Ghanaian population with a high pathogen exposure for selective advantages of APOE-ε4, to survival and or fertility.
Methods and findings: This rural Ghanaian population (n = 4311) has high levels of mortality from widespread infectious diseases which are the main cause of death. We examined whether APOE-ε4 was associated with survival (total follow-up time was 30,262 years) and fertility after stratifying by exposure to high or low pathogen levels. Households drawing water from open wells and rivers were classified as exposed to high pathogen levels while low pathogen exposure was classified as those drawing water from borehole wells. We found a non-significant, but positive survival benefit, i.e. the hazard ratio per APOE-ε4 allele was 0.80 (95% confidence interval: 0.69 to 1.05), adjusted for sex, tribe, and socioeconomic status. Among women aged 40 years and older (n = 842), APOE-ε4 was not associated with the lifetime number of children. However, APOE-ε4 was associated with higher fertility in women exposed to high pathogen levels. Compared with women not carrying an APOE-ε4 allele, those carrying one APOE-ε4 allele had on average one more child and those carrying two APOE-ε4 alleles had 3.5 more children (p = 0.018).
Conclusions: Contrary to affluent modern-day populations, APOE-ε4 did not carry a survival disadvantage in this rural Ghanaian population. Moreover, APOE-ε4 promotes fertility in highly infectious environments. Our findings suggest that APOE-ε4 may be considered as evolutionarily adaptive. Its adverse associations in affluent modern populations with later onset diseases of aging further characterize APOE-ε4 as an example of antagonistic pleiotropy.
Conflict of interest statement
Figures
Similar articles
-
Apolipoprotein-ε4 is associated with higher fecundity in a natural fertility population.Sci Adv. 2023 Aug 9;9(32):eade9797. doi: 10.1126/sciadv.ade9797. Epub 2023 Aug 9. Sci Adv. 2023. PMID: 37556539 Free PMC article.
-
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.Am J Pathol. 1996 Jun;148(6):2083-95. Am J Pathol. 1996. PMID: 8669492 Free PMC article.
-
Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.Arch Neurol. 2006 Nov;63(11):1586-90. doi: 10.1001/archneur.63.11.1586. Arch Neurol. 2006. PMID: 17101827
-
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060. JAMA Psychiatry. 2014. PMID: 25162367
-
Could aging evolve as a pathogen control strategy?Trends Ecol Evol. 2022 Dec;37(12):1046-1057. doi: 10.1016/j.tree.2022.08.003. Epub 2022 Sep 9. Trends Ecol Evol. 2022. PMID: 36096982 Review.
Cited by
-
A review of the roles of pathogens in Alzheimer's disease.Front Neurosci. 2024 Aug 19;18:1439055. doi: 10.3389/fnins.2024.1439055. eCollection 2024. Front Neurosci. 2024. PMID: 39224577 Free PMC article. Review.
-
Apolipoprotein E polymorphisms and female fertility in a transgenic mouse model of Alzheimer's disease.Sci Rep. 2024 Jul 10;14(1):15873. doi: 10.1038/s41598-024-66489-w. Sci Rep. 2024. PMID: 38982272 Free PMC article.
-
Characterizing the pathogenicity of genetic variants: the consequences of context.NPJ Genom Med. 2024 Jan 9;9(1):3. doi: 10.1038/s41525-023-00386-5. NPJ Genom Med. 2024. PMID: 38195641 Free PMC article.
-
Lower mortality risk in APOE4 carriers with normal cognitive ageing.Sci Rep. 2023 Sep 12;13(1):15089. doi: 10.1038/s41598-023-41078-5. Sci Rep. 2023. PMID: 37699966 Free PMC article.
-
Apolipoprotein-ε4 is associated with higher fecundity in a natural fertility population.Sci Adv. 2023 Aug 9;9(32):eade9797. doi: 10.1126/sciadv.ade9797. Epub 2023 Aug 9. Sci Adv. 2023. PMID: 37556539 Free PMC article.
References
-
- Mahley RW, Rall SC Jr. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 2000; 1:507–537. doi: 10.1146/annurev.genom.1.1.507 - DOI - PubMed
-
- Franceschini N, Carty C, Bůzková P, Reiner AP, Garrett T, Lin Y, et al. Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study. Circ. Cardiovasc. Genet. 2011; 4:661–672. doi: 10.1161/CIRCGENETICS.111.960096 - DOI - PMC - PubMed
-
- Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349:151–4. doi: 10.1016/S0140-6736(96)09328-2 - DOI - PubMed
-
- Humphries SE, Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol. 2004; 3:227–35. doi: 10.1016/S1474-4422(04)00708-2 - DOI - PubMed
-
- Kulminski AM, Culminskaya I, Ukraintseva SV, Arbeev KG, Arbeeva L, Wu D, et al. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell 2011; 10:533–541. doi: 10.1111/j.1474-9726.2011.00689.x - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous